Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.75 approved,investigational inhibitor
panobinostat histone deacetylase 1 NA Successful target TTD , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.75 approved unknown
panobinostat histone deacetylase 1 NA Successful target TTD , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.75 approved inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.21 approved,investigational inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.24 approved,investigational inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.44 approved,investigational inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.45 approved,investigational inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.37 approved,investigational inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.2 approved,investigational inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.43 approved,investigational inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.4 approved,investigational inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.27 approved,investigational inhibitor
panobinostat histone deacetylase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Primary Myelofibrosis[MeSHID:D055728]		 0.44 approved,investigational inhibitor
click here to return to the previous page